Halozyme Therapeutics
UEI: L29GR1FX5L24
• CAGE: 5N8N3
Overview
Awardee Type
Parent
Name
Halozyme Therapeutics
Website
Headquarters
San Diego, CA
United States
United States
Federal recipient
HALOZYME THERAPEUTICS, INC
(UEI L29GR1FX5L24, CAGE 5N8N3)
is headquartered in San Diego CA.
Its primary registered NAICS is 424210 Drugs and Druggists' Sundries Merchant Wholesalers.
The corporation
was founded in February 1998 and
federally registered in
August 2009.
Federal Registration and Certifications
Legal Name
HALOZYME THERAPEUTICS, INC
Division Name
RESEARCH
UEI
L29GR1FX5L24
CAGE Code
5N8N3
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 26, 1998
Initial Registration
Aug. 19, 2009
Last Registration
June 14, 2024
Registration Activation
June 20, 2023
Registration Expiration
June 14, 2024
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
CA
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Halozyme Therapeutics
GSA Schedules and Price Lists
- Halozyme Therapeutics
- PoP: 1/14/19 - 12/19/23 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)